ADVERTISEMENT

Custom Search
Today's Health Headlines
NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

DAKAR (Reuters) - With more than twice as many Ebola outbreaks as any other country since the virus was discovered in 1976, Congolese are familiar with its destructive power, yet fear and suspicion of medical authorities are still hindering efforts at containment.

LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting prospects for a medicine that has already got off to a promising commercial launch.

MUMBAI (Reuters) - Officials in a third Indian state were checking on Friday if two people had been infected with the brain-damaging Nipah virus that has killed 12 in southern Kerala, although the government described the outbreak as minor.

(Reuters Health) - For the past four years, since Facebook and Apple began paying for employees to freeze their eggs to delay childbirth, healthy women are increasingly trying to slow their biological clocks by banking their oocytes, or eggs.

Food insecurity linked to type 2 diabetes risk
Fri, 25 May 2018 12:52:53 -0400
(Reuters Health) - Canadians who cannot afford to eat regularly or to eat a healthy diet have more than double the average risk of developing type 2 diabetes, a study suggests.

(Reuters Health) - Heart disease death rates vary substantially at Veterans Affairs hospitals nationwide, and a new study suggests that this holds true not just for hospitalized patients but also for outpatients.

(Reuters) - A California jury on Thursday ordered Johnson & Johnson to pay $4 million in punitive damages to a woman who said she developed cancer after being exposed to asbestos in the company's baby powder, pushing the total damages award in the case to $25.7 million.

(Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.

WASHINGTON (Reuters) - The U.S. Environmental Protection Agency, under pressure from the chemical industry, has delayed release of a study detailing cancer risks from formaldehyde, according to internal communications seen by Reuters, potentially keeping important health information from the public.

Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading